Accelerating Discoveries in Newborn Screening
Every day, babies born in the United States receive comprehensive screening for treatable diseases. Newborn screening saves lives, and discoveries by researchers make it possible!
NBSTRN is designed for
Learn how to get started using the NBSTRN tools and resources today.
Research advances newborn screening by developing new screening and diagnostic tests and by discovering new treatments.
The NICHD-supported Newborn Screening Translational Research Network (NBSTRN) accelerates these efforts by developing tools, resources, and expertise available to researchers, healthcare professionals, families, advocacy groups, and state newborn screening programs.
Sign up to learn more about how NBSTRN helps advance newborn screening research.
Longitudinal Pediatric Data Resource (LPDR)
A central goal for NBSTRN is to foster collaboration between research teams, State NBS programs, clinicians, advocacy groups, patients, and families. The LPDR houses millions of data points from ground-breaking studies available for data mining, visualization and secondary research.
Connect with Our Community
Researchers
Design a study, contribute data, and analyze and share data using the Longitudinal Pediatric Data Resource (LPDR).
Healthcare Professionals
Explore the NBS Conditions Resource (NBS-CR), contribute data, and connect with specialists.
Families and Advocacy Groups
Connect with researchers and healthcare professionals and learn about NBS for your disease of interest.
State NBS Programs
Support NBS research and share longitudinal data to help understand health outcomes.
NBSTRN News & Events
Funding
The Newborn Screening Translational Research Network (NBTRN) is a key component of the Hunter Kelly Newborn Screening Research Program. The Hunter Kelly Newborn Research Program is operated by the Intellectual and Developmental Disabilities Branch (IDDB) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The American College of Medical Genetics and Genomics (ACMG) has operated the NBSTRN since 2008 with a contract from NICHD.
